Immunoprotein Diagnostic Testing Market Size, Share & Trends Analysis Report By Test, By Technology, By Application, By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2024 - 2030
![](/report_cover/9126/immunoprotein-diagnostic-testing-market-size-share-trends-analysis-report-by-test-by-technology-by-application-by-distribution-channel-by-end_en.gif)
This report can be delivered to the clients within 3 Business Days
Immunoprotein Diagnostic Testing Market Growth & Trends
The global immunoprotein diagnostic testing market size was valued at USD 14.86 billion in 2023 and is projected t%li%grow at a CAGR of 7.7% from 2024 t%li%2030. This growth can be attributed t%li%the rising incidence of chronic diseases.
According t%li%American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is als%li%taking initiatives t%li%reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected t%li%rise in order t%li%facilitate rapid diagnosis.
According t%li%WHO, nearly 1.69 million deaths due t%li%lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important t%li%reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved t%li%be highly effective in rapidly detecting chronic diseases.
Technological advancements in the field of immunoprotein diagnostics have led t%li%introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It als%li%measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.
Immunoprotein Diagnostic Testing Market Report Highlights
Immunoprotein Diagnostic Testing Market Growth & Trends
The global immunoprotein diagnostic testing market size was valued at USD 14.86 billion in 2023 and is projected t%li%grow at a CAGR of 7.7% from 2024 t%li%2030. This growth can be attributed t%li%the rising incidence of chronic diseases.
According t%li%American Heart Association’s 2017 statistics, nearly 790,000 people experience heart attack every year in the U.S. In addition, stroke is responsible for 1 in every 20 deaths in the U.S. Hence, WHO is als%li%taking initiatives t%li%reduce the risk of cardiovascular diseases. As a result of the aforementioned factors, the demand for immunoprotein diagnostics is expected t%li%rise in order t%li%facilitate rapid diagnosis.
According t%li%WHO, nearly 1.69 million deaths due t%li%lung cancer were registered in 2015 throughout the world. Hence, fast and accurate diagnosis of such chronic diseases has become important t%li%reduce the high mortality rate. Immunoprotein diagnostic devices and reagents have proved t%li%be highly effective in rapidly detecting chronic diseases.
Technological advancements in the field of immunoprotein diagnostics have led t%li%introduction of novel products. For instance, LIAISON XL, manufactured by DiaSorin, is a fully automated chemiluminescence analyzer that facilitates complete sample processing. It als%li%measures and evaluates testing samples, thereby, enhancing the efficiency and throughput of the system.
Immunoprotein Diagnostic Testing Market Report Highlights
- In 2016, immunoglobulin tests dominated the market owing t%li%their frequent usage by healthcare professionals for diagnosing infectious or autoimmune disorders
- C-Reactive Protein (CRP) tests held a significant market share in 2016 due t%li%the broad product portfoli%li%of these assays and reagents
- Infectious disease testing held largest market share in 2016 owing t%li%the increasing prevalence of infectious diseases and high applications of immunoprotein tests
- Enzyme-based immunoassays dominated the market in 2016 due t%li%their frequent usage and availability of large number of products that possess this technology
- Chemiluminescence assay is anticipated t%li%witness highest growth over the forecast period due t%li%its high sensitivity and specificity
- North America dominated the market in 2016 due t%li%rising prevalence of cancer & increase in mortality due t%li%cancer-related diseases and favorable healthcare reimbursement scenari%li%in the U.S.
- Some of the key players of immunoprotein diagnostic testing market are Bio-Rad Laboratories, Inc.; F. Hoffmann-La Roche AG; Abbott Laboratories; Enz%li%Biochem, Inc.; Therm%li%Fisher Scientific, Inc.; DiaSorin S.p.A; bioMC)rieux SA; and Siemens Healthcare GmbH
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunoprotein Diagnostic Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: TEST ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immunoprotein Diagnostic Testing Market: Test Movement Analysis, USD Million, 2023 & 2030
4.3. Complement System Proteins Diagnostic Tests
4.3.1. Complement System Proteins Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Free Light Chain Diagnostic Tests
4.4.1. Free Light Chain Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Haptoglobin Diagnostic Tests
4.5.1. Haptoglobin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Immunoglobulin Diagnostic Tests
4.6.1. Immunoglobulin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Prealbumin Diagnostic Tests
4.7.1. Prealbumin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. C-Reactive Protein (CRP) Diagnostic Tests
4.8.1. C-Reactive Protein (CRP) Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immunoprotein Diagnostic Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Infectious Disease Testing
5.3.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oncology Testing
5.4.1. Oncology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Endocrine Testing
5.5.1. Endocrine Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Toxicology Testing
5.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Allergy Testing
5.7.1. Allergy Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autoimmune Disease Testing
5.8.1. Autoimmune Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immunoprotein Diagnostic Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Radioimmunoassay
6.3.1. Radioimmunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Enzyme Based Immunoassay
6.4.1. Enzyme Based Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Chemiluminescence Assay
6.5.1. Chemiluminescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Immunofluorescence Assay
6.6.1. Immunofluorescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoturbidity Assay
6.7.1. Immunoturbidity Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Immunoprotein Electrophoresis
6.8.1. Immunoprotein Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Immunoprotein Diagnostic Testing Market: Material Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals and Clinics
7.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Immunoprotein Diagnostic Testing Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
8.3. Direct Tender
8.3.1. Direct Tender Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Retail Sales
8.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Immunoprotein Diagnostic Testing Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK.
9.3.2.1. UK Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Norway Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. India
9.4.3.1. India Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. Japan
9.4.4.1. Japan Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Australia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. South Korea Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. UAE Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Agilent Technologies, Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. Danaher Corporation.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Thermo Fisher Scientific Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. PerkinElmer Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Aurora Biomed Inc.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Tecan Trading AG
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Promega Corporation.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Charles River Laboratories
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Creative Biolabs
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives%%
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
CHAPTER 3. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET VARIABLES, TRENDS, & SCOPE
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. Immunoprotein Diagnostic Testing Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
CHAPTER 4. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: TEST ESTIMATES & TREND ANALYSIS
4.1. Segment Dashboard
4.2. Immunoprotein Diagnostic Testing Market: Test Movement Analysis, USD Million, 2023 & 2030
4.3. Complement System Proteins Diagnostic Tests
4.3.1. Complement System Proteins Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Free Light Chain Diagnostic Tests
4.4.1. Free Light Chain Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Haptoglobin Diagnostic Tests
4.5.1. Haptoglobin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Immunoglobulin Diagnostic Tests
4.6.1. Immunoglobulin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Prealbumin Diagnostic Tests
4.7.1. Prealbumin Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. C-Reactive Protein (CRP) Diagnostic Tests
4.8.1. C-Reactive Protein (CRP) Diagnostic Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 5. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: APPLICATION ESTIMATES & TREND ANALYSIS
5.1. Segment Dashboard
5.2. Immunoprotein Diagnostic Testing Market: Application Movement Analysis, USD Million, 2023 & 2030
5.3. Infectious Disease Testing
5.3.1. Infectious Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Oncology Testing
5.4.1. Oncology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Endocrine Testing
5.5.1. Endocrine Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Toxicology Testing
5.6.1. Toxicology Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Allergy Testing
5.7.1. Allergy Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.8. Autoimmune Disease Testing
5.8.1. Autoimmune Disease Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 6. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: TECHNOLOGY ESTIMATES & TREND ANALYSIS
6.1. Segment Dashboard
6.2. Immunoprotein Diagnostic Testing Market: Technology Movement Analysis, USD Million, 2023 & 2030
6.3. Radioimmunoassay
6.3.1. Radioimmunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Enzyme Based Immunoassay
6.4.1. Enzyme Based Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Chemiluminescence Assay
6.5.1. Chemiluminescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Immunofluorescence Assay
6.6.1. Immunofluorescence Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.7. Immunoturbidity Assay
6.7.1. Immunoturbidity Assay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.8. Immunoprotein Electrophoresis
6.8.1. Immunoprotein Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 7. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Segment Dashboard
7.2. Immunoprotein Diagnostic Testing Market: Material Movement Analysis, USD Million, 2023 & 2030
7.3. Hospitals and Clinics
7.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Diagnostic Laboratories
7.4.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Others
7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 8. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: DISTRIBUTION CHANNEL ESTIMATES & TREND ANALYSIS
8.1. Segment Dashboard
8.2. Immunoprotein Diagnostic Testing Market: Distribution Channel Movement Analysis, USD Million, 2023 & 2030
8.3. Direct Tender
8.3.1. Direct Tender Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
8.4. Retail Sales
8.4.1. Retail Sales Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 9. IMMUNOPROTEIN DIAGNOSTIC TESTING MARKET: REGIONAL ESTIMATES & TREND ANALYSIS
9.1. Immunoprotein Diagnostic Testing Market Share, By Region, 2023 & 2030, USD Million
9.2. North America
9.2.1. North America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.2. U.S.
9.2.2.1. U.S. Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.3. Canada
9.2.3.1. Canada Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.2.4. Mexico
9.2.4.1. Mexico Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3. Europe
9.3.1. Europe Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.2. UK.
9.3.2.1. UK Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.3. Germany
9.3.3.1. Germany Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.4. France
9.3.4.1. France Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.5. Italy
9.3.5.1. Italy Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.6. Spain
9.3.6.1. Spain Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.3.7. Norway
9.3.7.1. Norway Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4. Asia Pacific
9.4.1. Asia Pacific Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.2. China
9.4.2.1. China Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.3. India
9.4.3.1. India Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.4. Japan
9.4.4.1. Japan Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.5. Australia
9.4.5.1. Australia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.6. South Korea
9.4.6.1. South Korea Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.4.7. Thailand
9.4.7.1. Thailand Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5. Latin America
9.5.1. Latin America Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.2. Brazil
9.5.2.1. Brazil Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.5.3. Argentina
9.5.3.1. Argentina Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6. Middle East and Africa
9.6.1. Middle East and Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.2. South Africa
9.6.2.1. South Africa Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.3. Saudi Arabia
9.6.3.1. Saudi Arabia Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.4. UAE
9.6.4.1. UAE Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
9.6.5. Kuwait
9.6.5.1. Kuwait Immunoprotein Diagnostic Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
CHAPTER 10. COMPETITIVE LANDSCAPE
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Heat Map Analysis
10.4. Company Profiles
10.4.1. Agilent Technologies, Inc.
10.4.1.1. Participant’s Overview
10.4.1.2. Financial Performance
10.4.1.3. Product Benchmarking
10.4.1.4. Recent Developments/ Strategic Initiatives
10.4.2. Danaher Corporation.
10.4.2.1. Participant’s Overview
10.4.2.2. Financial Performance
10.4.2.3. Product Benchmarking
10.4.2.4. Recent Developments/ Strategic Initiatives
10.4.3. Thermo Fisher Scientific Inc.
10.4.3.1. Participant’s Overview
10.4.3.2. Financial Performance
10.4.3.3. Product Benchmarking
10.4.3.4. Recent Developments/ Strategic Initiatives
10.4.4. PerkinElmer Inc.
10.4.4.1. Participant’s Overview
10.4.4.2. Financial Performance
10.4.4.3. Product Benchmarking
10.4.4.4. Recent Developments/ Strategic Initiatives
10.4.5. Bio-Rad Laboratories, Inc.
10.4.5.1. Participant’s Overview
10.4.5.2. Financial Performance
10.4.5.3. Product Benchmarking
10.4.5.4. Recent Developments/ Strategic Initiatives
10.4.6. Aurora Biomed Inc.
10.4.6.1. Participant’s Overview
10.4.6.2. Financial Performance
10.4.6.3. Product Benchmarking
10.4.6.4. Recent Developments/ Strategic Initiatives
10.4.7. Tecan Trading AG
10.4.7.1. Participant’s Overview
10.4.7.2. Financial Performance
10.4.7.3. Product Benchmarking
10.4.7.4. Recent Developments/ Strategic Initiatives
10.4.8. Promega Corporation.
10.4.8.1. Participant’s Overview
10.4.8.2. Financial Performance
10.4.8.3. Product Benchmarking
10.4.8.4. Recent Developments/ Strategic Initiatives
10.4.9. Charles River Laboratories
10.4.9.1. Participant’s Overview
10.4.9.2. Financial Performance
10.4.9.3. Product Benchmarking
10.4.9.4. Recent Developments/ Strategic Initiatives
10.4.10. Creative Biolabs
10.4.10.1. Participant’s Overview
10.4.10.2. Financial Performance
10.4.10.3. Product Benchmarking
10.4.10.4. Recent Developments/ Strategic Initiatives%%
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Eye health supplements market: market outlook
Fig. 7 Eye health supplements competitive insights
Fig. 8 Parent market outlook
Fig. 9 Eye health supplements market driver impact
Fig. 10 Eye health supplements market restraint impact
Fig. 11 Eye health supplements market: Ingredient type movement analysis
Fig. 12 Eye health supplements market: Ingredient type outlook and key takeaways
Fig. 13 Lutein & zeaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Antioxidants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Omega-3 fatty acids market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 16 Coenzyme Q10 market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 17 Flavonoids market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Alpha-lipoic acid market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Astaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Eye health supplements market: Indication movement analysis
Fig. 22 Eye health supplements market: Indication outlook and key takeaways
Fig. 23 Age-related macular degeneration (AMD) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cataract market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Dry eye syndrome market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Inflammation market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Eye health supplements market: Formulation movement analysis
Fig. 29 Eye health supplements market: Formulation outlook and key takeaways
Fig. 30 Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Powder market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 33 Softgels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Liquid market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 North America eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Mexico eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Europe eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 UK eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Germany eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 France eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Italy eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Spain eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Denmark eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Sweden eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Norway eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 China eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Japan eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 India eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Korea eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Australia eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Latin America eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Brazil eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Africa eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Market formulation & validation
Fig. 6 Eye health supplements market: market outlook
Fig. 7 Eye health supplements competitive insights
Fig. 8 Parent market outlook
Fig. 9 Eye health supplements market driver impact
Fig. 10 Eye health supplements market restraint impact
Fig. 11 Eye health supplements market: Ingredient type movement analysis
Fig. 12 Eye health supplements market: Ingredient type outlook and key takeaways
Fig. 13 Lutein & zeaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 14 Antioxidants market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 15 Omega-3 fatty acids market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 16 Coenzyme Q10 market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 17 Flavonoids market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 18 Alpha-lipoic acid market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 19 Astaxanthin market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Eye health supplements market: Indication movement analysis
Fig. 22 Eye health supplements market: Indication outlook and key takeaways
Fig. 23 Age-related macular degeneration (AMD) market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Cataract market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 25 Dry eye syndrome market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 26 Inflammation market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Eye health supplements market: Formulation movement analysis
Fig. 29 Eye health supplements market: Formulation outlook and key takeaways
Fig. 30 Tablets market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 31 Capsules market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 Powder market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 33 Softgels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Liquid market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 North America eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 U.S. eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Canada eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Mexico eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Europe eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 UK eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Germany eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 France eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Italy eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Spain eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Denmark eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Sweden eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Norway eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 China eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Japan eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 India eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Thailand eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 South Korea eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Australia eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Latin America eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Brazil eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Argentina eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Middle East and Africa eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 South Africa eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 UAE eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Kuwait eye health supplements market estimates and forecasts, 2018 - 2030 (USD Million)